Advertisement
Advertisement

BPMC

BPMC logo

Blueprint Medicines Corporation

92.02
USD
-2.33
-2.47%
Feb 21, 16:00 UTC -5
Closed
exchange

After-Market

92.245

+0.23
+0.25%

Blueprint Medicines Corporation Profile

About

Blueprint Medicines Corporation is a biopharmaceutical company focused on developing the potentially transformational precision medicines to address patients with genomically defined cancers and rare diseases.

Info & Links

CEO

Kathryn Haviland

Headquarters

45 SIDNEY STREET
CAMBRIDGE, MA 02139, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.blueprintmedicines.com

Auditor

Ernst & Young LLP

Share holders

7

Employees

649

Blueprint Medicines Corporation Statistics

Valuation Measures

Market Capitalization2

5.90B

Enterprise Value

6.18B

Enterprise Value/EBITDA(ttm)

-28.32

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

11.81

Price to Book(mrq)

20.01

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

96.15%

Operating Margin(ttm)

-47.31%

Profit Margin(ttm)

-5.37%

Return on Equity(ttm)

-77.49%

Return on Invested Capital(ttm)

-6.82%

Return on Assets(ttm)

-20.84%

Income Statement

Revenue(ttm)

508.82M

Revenue Per Share(ttm)

7.96

Gross Profit(ttm)

488.66M

EBITDA(ttm)3

-218.22M

Net Income Available to Common(ttm)

-67.09M

Diluted EPS(ttm)

-1.08

Share Statistics

Beta (5Y Monthly)

0.62

52-Week Change

0.84%

S&P 500 52-Week Change

20.70%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

63.91M

Dividend Yield

0.00%

Float4

61.22M

% Held by Insiders

4.21%

% Held by Institutions

--

Balance Sheet

Total Cash(mrq)

615.49M

Total Cash Per Share(mrq)

9.63

Total Debt(mrq)

386.97M

Total Debt/Equity(mrq)

129.57%

Current Ratio(mrq)

2.85%

Quick Ratio(mrq)

2.80%

Book Value Per Share(mrq)

4.69

Cash Flow

Operating Cash Flow Per Share(ytd)

-3.06

Free Cash Flow(ytd)

-197.22M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement